I'm initiating coverage on Rani Therapeutics Holdings, Inc. (NASDAQ: RANI ) and believe that I should set it at a Buy rating. The reason why I believe that I should do this is Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broke ...

Rani Therapeutics Holdings (NASDAQ: RANI) shocked the stock market on Friday as its shares soared 248% to close at $1.64, following a collaboration with Japan’s Chugai Pharmaceutical.RANI one-day stock price chart. Source: Google Finance Rani’s stock jumped 222% in the past month, driven by investor excitement over its RaniPill technology, a capsule that delivers biologic drugs orally, replacing injections. The surge followed news of a collaboration with Chugai Pharmaceutical to develop an oral formulation ...

周五，Rani Therapeutics(RANI.US)飙升超265%，盘中一度熔断，股价创年内新高，报1.76美元。消息 面上，该公司宣布与中外制药Chugai达成高达10.85亿美元的合作协议，获得1000万美元预付款，并有 资格获得最高7500万美元技术转让与发展里程碑金、1亿美元销售里程碑金及个位数特许权使用费，同 时中外制药有权选择扩展至5个额外药物靶点。Rani Therapeutics主营生物制品口服递送技术，核心平台 RaniPill专注于口服抗体及罕见病药物开发，此次合作应用于中外制药的罕见病抗体项目，验证技术应 用价值。 ...

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $100 million in sales milestones and single digit royalties on product sales for the first license agreementChugai has the option to extend its rights to partner with Rani on up to 5 additional drug targets at similar deal terms bringing the total potential deal value to over $1 billionRani announced a $60.3 million private placement financing led by Samsara Bio ...

Our mission at Rani is to end painful injections for the millions of patients suffering from chronic diseases. Rani Therapeutics Fourth Quarter and Full Year Financial Results and Business Update March 31, 2025 1 Trade names, trademarks and service marks of other companies appearing in this presentation are the property of their respective owners. Solely for convenience, the trademarks and trade names referred to in this presentation appear without the ® and symbols, but those references are not intended to ...